Back
A.P. Møller-Mærsk A/S Vs. Crinetics Pharmaceuticals, Inc. Industry Stock Comparison
Buy
56
AMKBY
A.P. Møller-Mærsk A/S
Last Price:
$11.73
Seasonality Move:
-8.41%
Sell
34
CRNX
Crinetics Pharmaceuticals, Inc.
Last Price:
$53.24
Seasonality Move:
-11.9%
Buy
56
A.P. Møller-Mærsk A/S (AMKBY)
is a Buy
Is A.P. Møller-Mærsk A/S a Buy, Sell or Hold?
-
The current A.P. Møller-Mærsk A/S [AMKBY] share price is $11.77. The Score for AMKBY is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
-
AMKBY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
34
Crinetics Pharmaceuticals, Inc. (CRNX)
is a Sell
Is Crinetics Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Crinetics Pharmaceuticals, Inc. [CRNX] share price is $53.24. The Score for CRNX is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
-
CRNX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
AMKBY Stock Price Chart
What is A.P. Møller-Mærsk A/S's stock price today?
-
The A.P. Møller-Mærsk A/S share price today is $11.77The current trend is moderately bullish and AMKBY is experiencing slight selling pressure.
CRNX Stock Price Chart
What is Crinetics Pharmaceuticals, Inc.'s stock price today?
-
The Crinetics Pharmaceuticals, Inc. share price today is $53.24Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRNX is experiencing slight selling pressure.
AMKBY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.4 | Buy |
| Relative Strength Index (14 RSI): | 63.93 | Buy |
| Chaikin Money Flow: | -10944 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (10.65 - 11.79) | Buy |
| Bollinger Bands (100): | (9.75 - 11.07) | Buy |
CRNX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.28 | Buy |
| Relative Strength Index (14 RSI): | 65.68 | Buy |
| Chaikin Money Flow: | -209678 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (46.25 - 50.15) | Buy |
| Bollinger Bands (100): | (35.32 - 47.44) | Buy |
AMKBY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 11.71 | Buy |
| 20-day SMA: | 11.46 | Buy |
| 50-day SMA: | 10.59 | Buy |
| 200-day SMA: | 9.81 | Buy |
| 8-day EMA: | 11.75 | Buy |
| 20-day EMA: | 11.39 | Buy |
| 50-day EMA: | 10.84 | Buy |
| 200-day EMA: | 9.93 | Buy |
CRNX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 48.77 | Buy |
| 20-day SMA: | 48.57 | Buy |
| 50-day SMA: | 45.67 | Buy |
| 200-day SMA: | 36.1 | Buy |
| 8-day EMA: | 49.69 | Buy |
| 20-day EMA: | 48.35 | Buy |
| 50-day EMA: | 45.87 | Buy |
| 200-day EMA: | 40.28 | Buy |
A.P. Møller-Mærsk A/S Earnings Growth & AMKBY Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.89 per share, and a decrease next year of $0.00 per share.
Crinetics Pharmaceuticals, Inc. Earnings Growth & CRNX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.23 per share, and an increase next year of $1.51 per share.
A.P. Møller-Mærsk A/S Technical Analysis
| Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 5 | Jan 6 | Jan 7 | Jan 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 23 | 24 | 26 | 29 | 30 | 31 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Crinetics Pharmaceuticals, Inc. Technical Analysis
| Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 5 | Jan 6 | Jan 7 | Jan 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 23 | 24 | 26 | 29 | 30 | 31 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||